Meet the cast of The Iron Claw and join us as we delve into the captivating portrayal of this legendary wrestling dynasty and the talented actors ...

Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...

US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...

Tirzepatide was evaluated in two robust global clinical development programs. (Image Credits: Pexels) Eli Lilly and Company (India) on Thursday announced the launch of Mounjaro in single-dose vial ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country's drug regulator, it said on Thursday.

Wrestling was never the same after the Von Erich family stepped into the ring and took down their opponents with the famous Iron Claw move. But don't let their World Wrestling Federation (WWF) ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Steadman Pearson of Five Star has died age 60 (Picture: Eugene Adebari/Shutterstock) R&B icon Stedman Pearson has died age 60 after huge chart success in the 80s with his siblings in the band Five ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

Discouraging news from a rival dampened sentiment on the pharmaceutical giant's shares. This concerned a next-generation weight loss drug. That negative investor reaction was directed at companies ...